Table 4.
Study | Duration (Days) | Frequency and Character (Percentage of Patients, %) | Wexner Score (Percentage of Patients, %) | Gener Result 1 | |||
---|---|---|---|---|---|---|---|
Study Group | Control Group | Study Group | Control Group | Study Group | Control Group | ||
ADULTS POPULATION | |||||||
Chemotherapy treatment | |||||||
Liu J. et al. [36] | N/A | N/A | Markedly 2: 18 Effective 3: 78 Invalid 4: 4 |
Markedly: 8 Effective: 24 Invalid: 68 |
0–10: 37 11–20:13 21–30:0 |
0–10: 35 11–20: 15 21–30: 0 |
improvement |
CHILD POPULATION | |||||||
Chemotherapy treatment | |||||||
Reyna-Figueroa J. et al. [38] | up to 5 | up to 7 | N/A | N/A | N/A | N/A | improvement |
1 Significantly better outcomes in the study group in at least one parameter (α = 0.05); 2 Markedly: stool returned to normal and the frequency to once a day after treatment; 3 Effective: stool character improved and the frequency became more than 3 times per week after treatment; 4 Invalid: no improvement in frequency and character of stool after treatment.